Re: AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer: Editorial comment

Samir S. Taneja

    Research output: Contribution to journalComment/debatepeer-review

    Fingerprint Dive into the research topics of 'Re: AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer: Editorial comment'. Together they form a unique fingerprint.